Background: Congenital mesoblastic nephroma (CMN) is a rare tumour of the kidney with an overall excellent prognosis. Once considered a benign tumour, it is now recognized to carry a risk of recurrence and metastases with subsequent poor outcomes. The potential for genetic aberrations such as ETV6-NTRK3 fusion raises the potential for targeted treatments in certain patients. The optimum mode and frequency of surveillance is unclear. This study aims to assess this institution's experience with CMN and long-term outcomes.
Methods: A single centre retrospective review was performed of all confirmed cases of CMN between October 2001 and January 2021.
Results: Nine cases of CMN in patients under 12 months of age were identified. The histopathology, management and outcomes of these patients are discussed.
Conclusion: CMN overall has a very good prognosis, but a subgroup does exist that will have poor outcomes. It is difficult to accurately identify this group to target adjuvant therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ans.18165 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Paediatric renal tumours: an update on challenges and recent developments.
Virchows Arch
January 2025
Histology Laboratory, Children's Health Ireland, Dublin, Ireland.
Paediatric renal tumours include a broad range of neoplasms which largely differ, but also overlap to a smaller extent, with adult kidney cancer. These include the embryonal tumour nephroblastoma, which accounts for the majority of cases of kidney cancer in the first decade of life and, despite boasting a cure in ~ 90% cases, still presents clinical challenges in a small proportion of cases. A variety of less common mesenchymal tumours, including the mostly indolent congenital mesoblastic nephroma, clear cell sarcoma of kidney which continues to be associated with poor outcomes for higher stage disease, and the typically lethal malignant rhabdoid tumour, form the bulk of the remaining presentations in the first decade.
View Article and Find Full Text PDFCharacterization of malignant kidney tumors in childhood by F-FDG PET/CT.
World J Urol
December 2024
Department of Nuclear Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Kongjiang Road 1665, Yangpu District, Shanghai, 200092, China.
Article Synopsis
- The study examines how semiquantitative parameters from F-FDG PET/CT can help characterize pediatric kidney tumors, focusing on 54 children with confirmed malignant tumors.
- Results show that while PET parameters like SUVmax, MTV, and TLG detected all kidney tumors, only clear cell sarcoma had significantly lower FDG uptake compared to Wilms tumor.
- The findings highlight that specific PET metrics are closely linked to disease stage, with TLG being the best predictor for advanced stages, which could help in understanding genetic factors in Wilms tumor.
Congenital Peribronchial Myofibroblastic Tumors Harbor a Recurrent EGFR Kinase Domain Duplication.
Mod Pathol
November 2024
Department of Pathology, Stanford University School of Medicine, Stanford, California. Electronic address:
Article Synopsis
- - Congenital peribronchial myofibroblastic tumor (CPMT) is a rare benign tumor found in infants, identified by unique histological features, including cartilaginous islands and spindle cells, which can lead to serious complications despite its benign classification.
- - Genetic analysis reveals that a specific alteration, the EGFR kinase domain duplication (KDD), is a common oncogenic driver in CPMT cases, suggesting that CPMT and similar tumors, like congenital mesoblastic nephromas, may share underlying molecular mechanisms and be related.
- - Following surgical resection of the tumors, patients demonstrated varied outcomes; while one patient died shortly after surgery, the remaining three were free of recurrence, indicating
Congenital Mesoblastic Nephroma Mixed Subtype: A Case Report of a Rare Neonatal Tumor.
Cureus
October 2024
Department of Pathology, Armed Forces Hospital Southern Region, Khamis Mushait, SAU.
Congenital renal tumors are rare. In infancy, congenital mesoblastic nephroma is the most commonly reported renal tumor. It is recognized antenatally due to polyhydramnios and presents clinically as a palpable abdominal mass in the neonatal period.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!